Andrew Raubitschek

11.6k citations
157 papers · 9.1k indexed · 2 hit papers · h-index 53
Topics
Radiopharmaceutical Chemistry and Applications (80 papers)Monoclonal and Polyclonal Antibodies Research (63 papers)Lymphoma Diagnosis and Treatment (38 papers)

In The Last Decade

Andrew Raubitschek

153 papers receiving 8.8k citations

Hit Papers

Adoptive immunotherapy for indolent non-Hodgkin lymphoma ...200820262014202020082012100200300400500

Peers

Andrew Raubitschek
Comparison fields: 5 of 122
  • Oncology 4.3k
  • Radiology, Nuclear Medicine and Imaging 4.3k
  • Molecular Biology 2.7k
  • Immunology 2.2k
  • Pathology and Forensic Medicine 1.3k
Replace David Colcher with:
David Colcher United States
Jorge A. Carrasquillo United States
Irwin D. Bernstein United States
Neil H. Bander United States
Kenneth A. Foon United States
Zenon Steplewski United States
Guus A.M.S. van Dongen Netherlands
Tim Illidge United Kingdom
John M. Pagel United States
Silvana Canevari Italy
Andrew Raubitschek relative to David Colcher United States David Colcher's profile →
Citations per field
00.5×1.5×2.2×
David Colcher · 1×
Citations per year

Countries citing papers authored by Andrew Raubitschek

Since Specialization
Citations

This map shows the geographic impact of Andrew Raubitschek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Raubitschek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Raubitschek more than expected).

Fields of papers citing papers by Andrew Raubitschek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Raubitschek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Raubitschek. The network helps show where Andrew Raubitschek may publish in the future.

Co-authorship network of co-authors of Andrew Raubitschek

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Raubitschek. A scholar is included among the top collaborators of Andrew Raubitschek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Raubitschek. Andrew Raubitschek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 9
3 42
4 48
5
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsbreakdown →
431
6 29
7 29
8 22
9 35
10 196
11 14
12 47
13 31
14 26
15 59
16 8
17 189
18
A Shielded, Automated Injector for Energetic Beta-Emitting Radionuclides
1
19 16
20 16

About Andrew Raubitschek

Andrew Raubitschek is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine, having authored 157 papers that have together received 9.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (80 papers), Monoclonal and Polyclonal Antibodies Research (63 papers) and Lymphoma Diagnosis and Treatment (38 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (4.3k citations), Oncology (4.3k citations) and Immunology (2.2k citations). Andrew Raubitschek has collaborated with scholars based in United States, Slovakia and Sweden. Frequent co-authors include John E. Shively, Stephen J. Forman, Anna M. Wu, Lawrence E. Williams, Michael C. Jensen, David Colcher, Paul J. Yazaki, Jeffrey Y.C. Wong, Oliver W. Press and Philip D. Greenberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026